Latest Breaking News On - Company or biophytis - Page 1 : vimarsana.com

Biophytis S A : Interim Financial Report issued by the registrant on September 27, 2023 - Form 6-K -September 27, 2023 at 05:04 pm EDT

French public limited company with a Board of Directors with share capital of €4,267,706.99 Registered office: 14 Avenue de l Opéra - 75001 PARIS Paris Commercial Register .

United statesUnited kingdomFrance generalIntsel chimosClaude allaryNadine coulmJean marianiEuropean medicines agencyInternational accounting standardsResearch tax creditInternational financial reporting interpretations committeeBiophytis inc united statesCompany board of directors onCompanies registryDevelopment of sarconeosInternational accounting standards board

Biophytis has filed with the FDA for authorization to initiate SARA-31 phase 3 study in sarcopenia

Biophytis / Key word(s): Miscellaneous Biophytis has filed with the FDA for authorization to initiate SARA-31 phas.

United kingdomTufts universityUnited statesFrance generalNicolas fellmannAntoine denryNizar berradaAgathe boggioExchange commissionEuropean medicines agencyLaboratory at tufts universityCompany or biophytisDrug administrationEuronext growth parisEuropean medicinesMajor mobility disability

Biophytis Has Filed with The FDA For Authorization to Initiate SARA-31 Phase 3 Study in Sarcopenia

Biophytis Has Filed with The FDA For Authorization to Initiate SARA-31 Phase 3 Study in Sarcopenia
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

France generalUnited kingdomEuropean medicines agencyDrug administrationCompany or biophytisEuronext growth parisEuropean medicinesIhre watchlist

Biophytis Has Filed with The FDA For Authorization to Initiate SARA-31

Biophytis Has Filed with The FDA For Authorization to Initiate SARA-31 .

United statesFrance generalUnited kingdomNizar berradaAntoine denryNicolas fellmannAgathe boggioExchange commissionDrug administrationNews networkEuropean medicines agencyCompany or biophytisEuronext growth parisEuropean medicinesEmergency use authorizationDuchenne muscular dystrophy

Biophytis has Filed with the French National Authority for Health (HAS)

Biophytis has Filed with the French National Authority for Health (HAS) .

United statesFrance generalUnited kingdomIntsel chimosCorinne truffaultNicolas fellmannAntoine denryAgathe boggioFrench national authority for healthExchange commissionHealth productsCompany or biophytisNews networkNational agency for the safety of medicinesEuronext growth parisEarly access authorisation